Filing Details
- Accession Number:
- 0001708138-20-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 16:03:06
- Reporting Period:
- 2020-05-07
- Accepted Time:
- 2020-05-08 16:03:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1681643 | Y Huda Zoghbi | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-07 | 5,118 | $391.92 | 5,761 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-07 | 1,722 | $565.64 | 4,039 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 2,128 | $566.37 | 1,911 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 646 | $567.58 | 1,265 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 609 | $568.37 | 656 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 13 | $569.20 | 643 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-07 | 5,118 | $0.00 | 5,118 | $391.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,235 | 2026-09-09 | No | 4 | M | Direct |
Footnotes
- Represents volume-weighted average price of sales of 1,722 shares of Company stock on May 7, 2020 at prices ranging from $565.43 to $565.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
- Represents volume-weighted average price of sales of 2,128 shares of Company stock on May 7, 2020 at prices ranging from $566.00 to $566.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
- Represents volume-weighted average price of sales of 646 shares of Company stock on May 7, 2020 at prices ranging from $567.20 to $567.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
- Represents volume-weighted average price of sales of 609 shares of Company stock on May 7, 2020 at prices ranging from $568.05 to $568.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
